ORMEAU CLINICAL TRIALS

Our Experience

With an extensive history dating back to 2005, Ormeau Clinical Trials has been deeply involved in advancing clinical research for nearly two decades. Our involvement spans across various critical phases of clinical trials, encompassing Observational (Non-Interventional), Epidemiological, Phase II, Phase IIA, Phase III, Phase IIIB, and Phase IV studies. Collaborating with some of the biggest pharmaceutical companies in the industry, we have contributed significantly to the evolving landscape of medical research.

 

We possess extensive experience in various phases of human clinical trials, including:

 

  • Observational (Non Interventional)
  • Epidemiological
  • Phase II
  • Phase IIA
  • Phase III
  • Phase IIIB
  • Phase IV
 
 

There is a wide range of therapeutic areas on which we have expertise working with:​

 

  • Respiratory Asthma/COPD
  • Cardio Vascular Disease
  • Diabetes
  • Hyperlipidemia
  • Gastrointestinal (IBD, GORD, Opiate Induced Constipation)
  • Substance Abuse
  • Addictions
  • Alcohol Harm Reduction
  • Urology (Over Active bladder)
  • Vaccinations
  • Infectious Diseases
  • Epidemiology
  • Osteoporosis
  • Osteoarthritis
  • Genomic Basis of Multiple Diseases
  • Winter illness (Dr McNally was Chief investigator)

We have worked with a wide range of sponsors, which includes:

 

  • Amgen
  • AstraZeneca
  • Bellus
  • Chiesi
  • Gilead
  • GSK
  • Novartis
  • Novo Nordisk
  • Pfizer
  • Reckitt benckiser
  • Sanofi
 
 

As well as working with study sponsors, we have also have great working relationships with many Clinical Research Organisations (CROs), such as:​​

 

  • Covance
  • Eurofins
  • Fortrea
  • ICON
  • INC
  • Medpace
  • Parexel
  • PPD
  • PRA
  • Syneos